BioCentury | Apr 5, 1999
Company News

TerraGen Diversity, Xenova deal

...Discovery's previous collaborations, rights to Discovery's QTC libraries, and royalty-free access to the NatChem libraries. TerraGen Diversity Inc....
BioCentury | Apr 5, 1999
Company News

Xenova, EG&G deal

...and development, and high throughput screening services. The dissolution follows the sale of Discovery to TerraGen Diversity Inc....
BioCentury | Apr 5, 1999
Strategy

Breaking out of the box

...out of the box With its recent acquisitions of ChromaXome Corp. and Xenova Discovery Ltd., TerraGen Diversity Inc....
BioCentury | Apr 5, 1999
Strategy

Xenova's divestment strategy

...drugs. Last week the company announced that it was selling its Xenova Discovery business to TerraGen Diversity Inc....
BioCentury | Mar 29, 1999
Finance

Rothschild's exit

...include stakes in BioVector Therapeutics S.A. (Paris, France), EnCompass Bioinformatics Pty. Ltd. (Sydney, Australia), and TerraGen Diversity Inc....
BioCentury | Mar 22, 1999
Company News

TerraGen Diversity, Trega Biosciences Inc. deal

...600,000 shares of TerraGen preferred stock. TerraGen has 10.4 million shares outstanding after the acquisition. TerraGen Diversity Inc....
BioCentury | Feb 22, 1999
Company News

TerraGen Diversity scientific advisory board update

TerraGen Diversity Inc., Vancouver, B.C. Business: Drug discovery, Infectious diseases Appointed: Richard Baltz, visiting research advisor at Dow AgroSciences WIR Staff Infectious...
BioCentury | Dec 21, 1998
Company News

TerraGen Diversity, Schering-Plough Research Institute deal

...development. TerraGen will receive annual R&D payments and will be eligible for milestones and royalties. TerraGen Diversity Inc....
BioCentury | Aug 31, 1998
Emerging Company Profile

TerraGen Diversity Inc.

TerraGen Diversity Inc. Vancouver, B.C. Technology: Compound discovery by isolation of genomic DNA from uncultivable microorganisms Disease focus: Infectious diseases and cancer Clinical status: Preclinical Founded: 1996 by Julian Davies, the University of British Columbia...
BioCentury | Aug 31, 1998
Emerging Company Profile

TerraGen: Drugs from dirt

...While other companies have turned to combinatorial chemistry as an alternative to provide compound libraries, TerraGen Diversity Inc....
Items per page:
1 - 10 of 11
BioCentury | Apr 5, 1999
Company News

TerraGen Diversity, Xenova deal

...Discovery's previous collaborations, rights to Discovery's QTC libraries, and royalty-free access to the NatChem libraries. TerraGen Diversity Inc....
BioCentury | Apr 5, 1999
Company News

Xenova, EG&G deal

...and development, and high throughput screening services. The dissolution follows the sale of Discovery to TerraGen Diversity Inc....
BioCentury | Apr 5, 1999
Strategy

Breaking out of the box

...out of the box With its recent acquisitions of ChromaXome Corp. and Xenova Discovery Ltd., TerraGen Diversity Inc....
BioCentury | Apr 5, 1999
Strategy

Xenova's divestment strategy

...drugs. Last week the company announced that it was selling its Xenova Discovery business to TerraGen Diversity Inc....
BioCentury | Mar 29, 1999
Finance

Rothschild's exit

...include stakes in BioVector Therapeutics S.A. (Paris, France), EnCompass Bioinformatics Pty. Ltd. (Sydney, Australia), and TerraGen Diversity Inc....
BioCentury | Mar 22, 1999
Company News

TerraGen Diversity, Trega Biosciences Inc. deal

...600,000 shares of TerraGen preferred stock. TerraGen has 10.4 million shares outstanding after the acquisition. TerraGen Diversity Inc....
BioCentury | Feb 22, 1999
Company News

TerraGen Diversity scientific advisory board update

TerraGen Diversity Inc., Vancouver, B.C. Business: Drug discovery, Infectious diseases Appointed: Richard Baltz, visiting research advisor at Dow AgroSciences WIR Staff Infectious...
BioCentury | Dec 21, 1998
Company News

TerraGen Diversity, Schering-Plough Research Institute deal

...development. TerraGen will receive annual R&D payments and will be eligible for milestones and royalties. TerraGen Diversity Inc....
BioCentury | Aug 31, 1998
Emerging Company Profile

TerraGen Diversity Inc.

TerraGen Diversity Inc. Vancouver, B.C. Technology: Compound discovery by isolation of genomic DNA from uncultivable microorganisms Disease focus: Infectious diseases and cancer Clinical status: Preclinical Founded: 1996 by Julian Davies, the University of British Columbia...
BioCentury | Aug 31, 1998
Emerging Company Profile

TerraGen: Drugs from dirt

...While other companies have turned to combinatorial chemistry as an alternative to provide compound libraries, TerraGen Diversity Inc....
Items per page:
1 - 10 of 11